ARCHIVES

Cancer Program Should Get $2 Billion A Year, Amos Says; “Feds Short On Money, Long of Regs”: Yarbro

This article is from The Cancer Letter archive.

Vol. 09 No. 12 | March 25, 1983

Download PDF Visit The Full Archive

Related Articles

SWOG Five Drug Adjuvant Breast Study Shows Remarkable Survival For Older, Younger Women

March 30, 1979

IND-Exempt Trials May Need Special Review, HCFA Says.

September 29, 2000

Is $45 Million Too Much to Spend on PR? NCAB Panel Weighs NCI Communications Budget

December 7, 2012

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

January 25, 2008

Senate Approves $47 Million For More AIDs Drugs

September 19, 1986

Study Section Members Seek NIH Use Of Normalization, Sliding Scale

April 16, 1982